G
G

GSK


Nouvelles

Nestle CEO: I'm not a 'mega deal' maker

ZURICH, Sept 29 (Reuters) - Food group Nestle NESN.S is in no hurry to acquire companies given rich valuations and will stick to its traditionally cautious approach to deals, its chief executive told a conference on Thursday. "I've done hundreds of deals in my life, the largest one ever was Starbucks at 7 billion so I'm not a 'mega deal' maker," Mark Schneider said in a discussion organised by Bernstein.
G
N
S

British Business - Sept 27

Sept 27 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - Unilever plc ULVR.L is to start the search for a new chief executive officer after Alan Jope said that he intended to retire at the end of next year after five years in charge.
B
E
G
W

UK Stocks-Factors to watch on Sept 26

Sept 26 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher with futures FFIc1 up 0.51% on Monday. * UNILEVER: Unilever ULVR.L CEO Alan Jope plans to retire at the end of 2023, the maker of Dove soap and Knorr stock cubes said on Monday, roughly two months after activist investor Nelson Peltz joined the board. * GSK: GSK GSK.L named luxury fashion brand Burberry's BRBY.L Julie Brown as its new chief financial officer to succeed Iain Mackay, at a time when the British drugmaker is s
B
B
G
R
U

UK Stocks-Factors to watch on Sept 26

Sept 26 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher with futures FFIc1 up 0.28% on Monday. * GSK: British drugmaker GSK GSK.L has poached Burberry Group's BRBY.L finance chief to create a rare all-female executive leadership team, Sky News reported on Saturday. * BARCLAYS: Barclays BARC.L was sued in a proposed U.S. class action in which shareholders claimed they were defrauded in connection with the British bank's sale of $17.6 billion more debt than regulators had allowed
B
B
G
R
U

British Business - Sept 23

Sept 23 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times The asset management business of HSBC Holdings Plc HSBA.L has set out plans to cut investments in thermal coal, months after one of its former top executives caused a furore with his comments about climate change.
G
H
R

UK Stocks-Factors to watch on Sept 20

Sept 20 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Tuesday, with futures FFIc1 up 0.57%. * HALEON: Haleon HLN.L said it had notified GSK GSK.L and Pfizer PFE.N that it had rejected their requests for indemnification in relation to U.S.-based litigation over the heartburn drug, Zantac. * FULLER: Fuller, Smith & Turner FSTA.L warned that the global energy crisis would significantly raise its expected full-year costs for gas and electricity.
G
K
P
T
U

UK Stocks-Factors to watch on Aug 17

Aug 17 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening up 0.36%, with futures .FFIc1 up 0.15% on Wednesday. * BOOHOO: British online fashion retailer Boohoo BOOH.L said on Wednesday it had acquired a 7.1% stake in Revolution Beauty Group REVB.L , making it the fourth-largest shareholder of the beauty products maker. * PERSIMMON: Persimmon PSN.L forecast robust demand for new homes and reiterated its annual home completions outlook, dispelling fears of a slowdown in the sector, althoug
C
G
P
U

Financial Times - Aug 17

Aug 17 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - Liz Truss and Rishi Sunak rule out second Scottish independence vote Link - UK launches legal proceedings against EU over access to Horizon programme Link - AstraZeneca sues former executive over move to rival GSK Link - Philips chief exits in wake of fallout from medical device recall Link Overview - Foreign secretary Liz Truss, f
A
G
P

UK first to approve Omicron COVID shot with Moderna nod

* UK's JCVI backs using bivalent shot in autumn booster campaign * Moderna sees Australia, Canada, EU approvals soon By Natalie Grover LONDON, Aug 15 (Reuters) - Britain, the first country to approve a coronavirus vaccine in late 2020, has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the virus.
A
G
P
S

Haleon not a party to U.S. litigation focused on Zantac - spokesperson

By Natalie Grover LONDON, Aug 11 (Reuters) - Haleon - GSK's recently spun off consumer health unit - is not a party to U.S. litigation focused on the heartburn medicine Zantac, a spokesperson told Reuters on Thursday. "We have never marketed Zantac in any form in the U.S., as Haleon or as GSK consumer healthcare," the spokesperson said, responding to Reuters querying a near-20% decline in Haleon's share price this week.
G
P
S

Haleon not a party to U.S. litigation focused on Zantac - spokesperson

LONDON, Aug 11 (Reuters) - Haleon - GSK's recently spun off consumer health unit - is not a party to the U.S. litigation focused on the heartburn medicine Zantac, a spokesperson told Reuters on Thursday. "We have never marketed Zantac in any form in the U.S., as Haleon or as GSK consumer healthcare," the spokesperson said in response to queries about sharp declines in Haleon shares.
G
S

FTSE 100 ends down as GSK slumps, eyes on GDP data

(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window) * Rio Tinto down on ex-dividend trading * GSK, Haleon slide on U.S. litigation concerns * Network International jumps on share buyback, earnings * FTSE 100 down 0.6%, FTSE 250 off 0.3% (Updates with market close) By Sruthi Shankar Aug 11 (Reuters) - Britain's main stock indexes closed lower on Thursday, with the blue-chip FTSE 100 hit by a slump in healthcare stocks and the midcap index slippin
A
A
G
N
R
U

FTSE 100 stalls as Rio Tinto, healthcare stocks weigh

(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window) * FTSE 100 flat, FTSE 250 adds 0.4% Aug 11 (Reuters) - Britain's top share index was flat on Thursday, weighed down by Rio Tinto and healthcare stocks, while the midcap index hit a fresh two-month high as global equities extended gains on relief from softer-than-expected U.S.
G
U

UK Stocks-Factors to watch on July 29

July 29(Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Friday, with futures FFIc1 up 0.35%. * ASTRAZENECA: AstraZeneca AZN.L topped analyst expectations for second-quarter profit and revenue, helped by higher demand for its cancer medicines. * IAG: IAG IAG.L returned to quarterly profitability for the first time since the outbreak of the COVID-19 pandemic, following a "significant" increase in capacity.
A
C
E
G
G
I
I
J
R
S
U

UK Stocks-Factors to watch on July 29

July 29(Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Friday, with futures FFIc1 up 0.2%. * STANCHART: Standard Chartered STAN.L on Friday reported that first-half pre-tax profit rose 19%, above market expectations, as the emerging markets-focused lender benefited from rising interest rates. * BUSINESS SENTIMENT: British business confidence fell this month to its lowest since March 2021 as companies worried about inflation, while pay pressures also increased, according to a
A
C
E
G
G
I
I
J
R
S
U

Cost of living crisis? Consumers keep spending for now

By Richa Naidu and Sachin Ravikumar LONDON, July 27 (Reuters) - Consumer-focused firms are seeing no shortage of demand despite the soaring cost-of-living, prompting several to upgrade sales forecasts for the current year, though questions remain about how long that will last. While some consumers are shielding themselves from price hikes by trading down to own label products, enough are spending more for McDonalds MCD.N to risk lifting the price of a cheeseburger in Britain for the first time i
C
D
G
L
P
K

UK Stocks-Factors to watch on July 27

July 27 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Wednesday, with futures FFIc1 up 0.34%. * MARSTON'S: British pub group Marston's MARS.L said its sales for 42 weeks was lower compared with pre-pandemic levels, as consumers spent less and recent hot weather kept people indoors. * BAT: Lucky Strike cigarette maker British American Tobacco BATS.L reported a drop in its first-half profit, driven by impairment charges related to transfer of its Russian business.
B
F
G
G
L
S
U

UK Stocks-Factors to watch on July 27

July 27 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Wednesday, with futures FFIc1 up 0.3%. * DE LA RUE: Britain's De La Rue DLAR.L has terminated its supply agreement with paper-making firm Portals Paper Ltd as the banknote printer cuts costs during a worldwide transition to polymer banknotes, the printer said on Tuesday. * REGULATOR: Britain's financial watchdog said on Wednesday it would press ahead with tougher protections for retail customers that put senior official
B
F
G
G
L
S
U

European shares trim gains on gas supply concerns

(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window) * Energy, banking, mining stocks lead gains in Europe * Just Eat, Delivery Hero rise as peer confirms margin target (Updates to close) By Susan Mathew and Bansari Mayur Kamdar July 18 (Reuters) - European stocks slipped from session highs after a report that Russia's Gazprom has declared force majeure on some gas supplies to Europe stoked worries about an energy crunch in the continent.
C
G
E
F
G

UK Stocks-Factors to watch on July 18

July 18(Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Monday, with futures FFIc1 up 0.53%. * JOHNSON MATTHEY: Johnson Matthey JMAT.L said on Monday it is building an 80 million pound ($95.08 million) gigafactory as it looks to expand manufacturing of hydrogen fuel cell components in the UK. * GSK: British drugmaker GSK GSK.L spun off its consumer health business on Monday in the biggest listing in Europe for more than a decade.
B
G
S
J
R
U



Conditions

Actifs populaires

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Nous utilisons des cookies pour vous donner la meilleure expérience possible de notre site internet. En savoir plus ou modifier vos paramètres de cookies.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques